レプチン受容体アゴニストのパイプライン・インサイト2019

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2016422)
◆英語タイトル:Leptin Receptor (LEP-R) Agonists -Pipeline Insights, 2019
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2016422
◆発行日:2019年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥135,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[レプチン受容体アゴニストのパイプライン・インサイト2019]についてメールでお問い合わせはこちら
本調査レポートでは、世界におけるレプチン受容体アゴニストのパイプライン動向について調査・分析し、以下の構成でお届けいたします。

・レプチン受容体アゴニストの概要
・レプチン受容体アゴニストのパイプライン概要
・企業別開発中のレプチン受容体アゴニスト
・後期治験段階の薬剤(Filed & Phase III):比較分析
・中期治験段階の薬剤(Phase II):比較分析
・初期治験段階の薬剤(Phase I & IND Filed):比較分析
・薬剤候補のプロファイル
・レプチン受容体アゴニストの評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価
・開発が中止された薬剤リスト
・開発休止中の薬剤リスト
・レプチン受容体アゴニスト開発に取り組んでいる企業リスト
・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “Leptin Receptor (LEP-R) Agonists-Pipeline Insights, 2019”, report provides in depth insights on the pipeline drugs and their development activities around the Leptin Receptor (LEP-R) Agonists. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Leptin Receptor (LEP-R) Agonists. DelveInsight’s Report also assesses the Leptin Receptor (LEP-R) Agonists therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitive pipeline landscape of Leptin Receptor (LEP-R) Agonists
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Leptin Receptor (LEP-R) Agonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Leptin Receptor (LEP-R) Agonists and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Leptin Receptor (LEP-R) Agonists Overview
• Leptin Receptor (LEP-R) Agonists Disease Associated
• Leptin Receptor (LEP-R) Agonists Pipeline Therapeutics
• Leptin Receptor (LEP-R) Agonists Therapeutics under Development by Companies
• Leptin Receptor (LEP-R) Agonists Filed and Phase III Products
• Comparative Analysis
• Leptin Receptor (LEP-R) Agonists Phase II Products
• Comparative Analysis
• Leptin Receptor (LEP-R) Agonists Phase I and IND Filed Products
• Comparative Analysis
• Leptin Receptor (LEP-R) Agonists Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Leptin Receptor (LEP-R) Agonists – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Leptin Receptor (LEP-R) Agonists – Discontinued Products
• Leptin Receptor (LEP-R) Agonists – Dormant Products
• Companies Involved in Therapeutics Development for Leptin Receptor (LEP-R) Agonists
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Leptin Receptor (LEP-R) Agonists by Therapy Area, 2019
• Number of Products under Development for Leptin Receptor (LEP-R) Agonists, 2019
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2019
• Comparative Analysis Phase II Products, 2019
• Comparative Analysis Phase I and IND Filed Products, 2019
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2019
• Drug Candidates Profiles
• Leptin Receptor (LEP-R) Agonists Assessment by Monotherapy Products
• Leptin Receptor (LEP-R) Agonists Assessment by Combination Products
• Leptin Receptor (LEP-R) Agonists Assessment by Route of Administration
• Leptin Receptor (LEP-R) Agonists Assessment by Stage and Route of Administration
• Leptin Receptor (LEP-R) Agonists Assessment by Molecule Type
• Leptin Receptor (LEP-R) Agonists Assessment by Stage and Molecule Type
• Leptin Receptor (LEP-R) Agonists Therapeutics – Discontinued Products
• Leptin Receptor (LEP-R) Agonists Therapeutics – Dormant Products
• Products under Development by Companies, 2019


List of Figures
• Number of Products under Development for Leptin Receptor (LEP-R) Agonists by Therapy Area, 2019
• Number of Products under Development for Leptin Receptor (LEP-R) Agonists, 2019
• Filed and Phase III Products, 2019
• Phase II Products, 2019
• Phase I and IND Filed Products, 2019
• Discovery and Pre-Clinical Stage Products, 2019
• Leptin Receptor (LEP-R) Agonists Assessment by Monotherapy Products
• Leptin Receptor (LEP-R) Agonists Assessment by Combination Products
• Leptin Receptor (LEP-R) Agonists Assessment by Route of Administration
• Leptin Receptor (LEP-R) Agonists Assessment by Stage and Route of Administration
• Leptin Receptor (LEP-R) Agonists Assessment by Molecule Type
• Leptin Receptor (LEP-R) Agonists Assessment by Stage and Molecule Type


*** レポートのキーワード ***

レプチン受容体アゴニスト、医薬品、製薬、研究開発、パイプライン、治療、治験

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • フレーバーミルク市場:グローバル産業動向・シェア・規模・成長・機会・予測
    IMARC’s latest study “Flavoured Milk Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” provides a techno-commercial roadmap for setting up a flavoured milk manufacturing plant. According to the report, the global flavoured milk market grew at a CAGR of 4.5% dur …
  • 光学式選別機の世界及び中国市場 2018年
    The 'Global and Chinese Optical Sorting Machines Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Optical Sorting Machines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Op …
  • 世界の海底生産システム市場2020-2024
    Global Subsea Production Systems Market 2020-2024 Technavio has been monitoring the subsea production systems market and it is poised to grow by $ 1 bn during 2020-2024 progressing at a CAGR of 3% during the forecast period. Our reports on subsea production systems market provides a holistic analysi …
  • 世界の熱可塑性EPDMゴム市場2017
    Thermoplastic EPDM Rubber Market Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Unit …
  • ポーランドのテレフタル酸ジメチル(DMT)市場(~2019):市場規模、シェア、動向
    Dimethyl Terephthalate (DMT) Industry Outlook in Poland to 2019 - Market Size, Price Trends and Trade Balance Summary GlobalData’s new report, "Dimethyl Terephthalate (DMT) Industry Outlook in Poland to 2019 - Market Size, Price Trends and Trade Balance", provides in-depth coverage of Poland’s Dimet …
  • Tech Data Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tech Data Corporation Mergers a …
  • 獣医イメージングの世界市場予測2018-2023
    Veterinary imaging instruments include radiography systems, ultrasound systems, CT systems, MRI systems, video endoscopy systems, and other imaging systems. Asia-Pacific is expected to register the highest CAGR during the forecast period. Growth in pet adoption, increasing awareness about animal hea …
  • 4-n-アミルフェノールの世界市場2021
    The Global 4-N-Amylphenol (CAS 14938-35-3) Industry 2021 Market Research Report is a professional and in-depth study on the current state of the 4-N-Amylphenol industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry ch …
  • パウダーコーティング装置の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Powder Coatings Equipment Revenue, means the sales value of Powder Coatings Equipment This report studies sales (consumption) of Powder Coatings Equipment in Global market, especially in United States, China, Europe and Japan, focuses on top players in these re …
  • ユビキチン酵素の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Ubiquitin Enzymes Revenue, means the sales value of Ubiquitin Enzymes This report studies sales (consumption) of Ubiquitin Enzymes in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sa …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2016422 )"レプチン受容体アゴニストのパイプライン・インサイト2019" (英文:Leptin Receptor (LEP-R) Agonists -Pipeline Insights, 2019)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。